Lannett Co. plans to acquire Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic drug subsidiary of UCB S.A., in a $1.23 billion deal. Lannett said late Wednesday that the acquisition will add a diversified commercial product portfolio of 18 products.
This month, Sam’s Club pharmacies plan to hold free diabetes screenings for club members and the public. The Walmart warehouse club chain said Wednesday that the screenings, to be offered on Sept.
Sandoz has launched a rivastigmine patch, a treatment for dementia, in the U.S. market. The Novartis subsidiary said Wednesday that its rivastigmine transdermal system is an authorized generic version of the Exelon patch, marketed by Novartis Pharmaceuticals Corp.
J M Smith Corp. has acquired pharmacy-related technology products and services offered by Integra NV and will manage them as a subsidiary called Integra LTC Solutions LLC.
Sanofi and the life sciences team at Google have formed a collaboration to improve care and outcomes for people with type 1 and type 2 diabetes.
Perrigo Co. plc has acquired the ScarAway scar management brand from Enaltus LLC. Financial terms of the transaction weren’t disclosed. Perrigo said Monday that Scaraway is expected to generate overall 2015 net sales of $10 million, or approximately $3 million for the remainder of the year.
Early feedback on the Food and Drug Administration’s proposal on naming conventions for biosimilars shows a mixed response.
Novo Nordisk plans to acquire Calibrium LLC and MB2 LLC, two privately held biopharmaceutical research companies based in Carmel, Ind.
Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for entecavir tablets 0.5 mg and 1 mg, a medication for hepatitis B. Aurobindo, which announced the product this week, said its entecavir tablets are a generic version of Baraclude tablets (0.
Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co. have received approval from the Food and Drug Administration for Synjardy tablets, a medication for type 2 diabetes.
CVS Health has formed new clinical affiliations with St. Luke’s University Health Network in Bethlehem, Pa., and TriHealth in Cincinnati.
Alvogen has entered an agreement to buy a portfolio of four U.S. pharmaceutical products from Pfizer Inc. Under the deal announced Wednesday, Alvogen plans to acquire three injectable products — Clindamycin, Voriconazole and Melphalan — and one inhaled solution product, Acetylcysteine.
Too many people still don’t feel the need to get a flu shot, a new survey from Kmart Pharmacy finds. Of more than 10,000 U.S. adults polled online, 41% said they typically don’t get a flu shot — even though 94% agree some people are particularly vulnerable to getting the flu
CVS Health has stepped up efforts to provide telehealth services through pilots with a trio of telemedicine technology companies.
Amneal Pharmaceuticals LLC has formed Amneal Biosciences, a new business unit.
Ateb Inc. this week kicked off its first branding campaign, dubbed “Driving Healthy Outcomes for Patients, Pharmacies and Payers.
